Markets & Finance

B of A Frowns on Amgen-Immunex Merger


Bank of America says that an acquisition of Immunex (AMGN) by Amgen (AMGN) would make strategic sense, but not financial sense, for Amgen.

Analyst Eric Ende says a stock and cash deal would be mostly in accordance with management's public statements about a potential acquisition. He says the acquisition would meet five out of the six criteria set by management, but it appears dilutive, thus missing the most important criteria. Also it would shift Amgen's focus away from its launch of Aranesp.


Silicon Valley State of Mind
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

 
blog comments powered by Disqus